Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Meridian Bioscience Inc.

    NASDAQ: VIVO · Real-Time Price · USD
    33.97
    0.00 (0.00%)
    At close: Jan 30, 2023, 10:00 PM

    Meridian Bioscience Statistics

    Share Statistics

    Meridian Bioscience has 43.83M shares outstanding. The number of shares has increased by 1.15% in one year.

    Shares Outstanding

    n/a
    		 43.83M

    Shares Change (YoY)

    n/a
    		 1.15%

    Shares Change (QoQ)

    n/a
    		 0.58%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 41.15M

    Failed to Deliver (FTD) Shares

    n/a
    		 4

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is 32.68 and the forward PE ratio is null. Meridian Bioscience's PEG ratio is -0.8.

    PE Ratio

    n/a
    		 32.68

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 4.17

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 3.77

    P/FCF Ratio

    n/a
    		 18.82

    PEG Ratio

    n/a
    		 -0.8
    Financial Ratio History

    Enterprise Valuation

    Meridian Bioscience has an Enterprise Value (EV) of 1.34B.

    EV / Sales

    n/a
    		 4.02

    EV / EBITDA

    n/a
    		 18.57

    EV / EBIT

    n/a
    		 16.24

    EV / FCF

    n/a
    		 18.13

    Financial Position

    The company has a current ratio of 3.63, with a Debt / Equity ratio of 0.08.

    Current Ratio

    n/a
    		 3.63

    Quick Ratio

    n/a
    		 2.46

    Debt / Equity

    n/a
    		 0.08

    Debt / EBITDA

    n/a
    		 0.43

    Debt / FCF

    n/a
    		 0.42

    Interest Coverage

    n/a
    		 46.68

    Financial Efficiency

    Return on Equity is 11.54% and Return on Invested Capital is 10.87%.

    Return on Equity

    n/a
    		 11.54%

    Return on Assets

    n/a
    		 9.17%

    Return on Invested Capital

    n/a
    		 10.87%

    Revenue Per Employee

    n/a
    		 $482,634.78

    Profits Per Employee

    n/a
    		 $61,534.78

    Employee Count

    n/a
    		 690

    Asset Turnover

    n/a
    		 0.72

    Inventory Turnover

    n/a
    		 2.13

    Taxes

    Income Tax

    n/a
    		 11.86M

    Effective Tax Rate

    n/a
    		 21.83%

    Stock Price Statistics

    The stock price has increased by 0% in the last 52 weeks. The beta is 0, so Meridian Bioscience's price volatility has been lower than the market average.

    Beta

    n/a
    		 0

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 32.89

    200-Day Moving Average

    n/a
    		 31.01

    Relative Strength Index (RSI)

    n/a
    		 71.24

    Average Volume (20 Days)

    n/a
    		 686,607

    Income Statement

    In the last 12 months, Meridian Bioscience had revenue of 333.02M and earned 42.46M in profits. Earnings per share was 0.96.

    Revenue

    n/a
    		 333.02M

    Gross Profit

    n/a
    		 188.36M

    Operating Income

    n/a
    		 55.51M

    Net Income

    n/a
    		 42.46M

    EBITDA

    n/a
    		 72.02M

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 0.96
    Full Income Statement

    Balance Sheet

    The company has 81.45M in cash and 30.96M in debt, giving a net cash position of 50.5M.

    Cash & Cash Equivalents

    n/a
    		 81.45M

    Total Debt

    n/a
    		 30.96M

    Net Cash

    n/a
    		 50.5M

    Retained Earnings

    n/a
    		 223.16M

    Total Assets

    n/a
    		 456.76M

    Working Capital

    n/a
    		 122.96M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 82.36M and capital expenditures -8.62M, giving a free cash flow of 73.75M.

    Operating Cash Flow

    n/a
    		 82.36M

    Capital Expenditures

    n/a
    		 -8.62M

    Free Cash Flow

    n/a
    		 73.75M

    FCF Per Share

    n/a
    		 1.68
    Full Cash Flow Statement

    Margins

    Gross margin is 56.56%, with operating and profit margins of 16.67% and 12.75%.

    Gross Margin

    n/a
    		 56.56%

    Operating Margin

    n/a
    		 16.67%

    Pretax Margin

    n/a
    		 16.31%

    Profit Margin

    n/a
    		 12.75%

    EBITDA Margin

    n/a
    		 21.63%

    EBIT Margin

    n/a
    		 16.67%

    FCF Margin

    n/a
    		 22.14%

    Dividends & Yields

    VIVO pays an annual dividend of $0.62, which amounts to a dividend yield of 3.18%.

    Dividend Per Share

    n/a
    		 $0.62

    Dividend Yield

    n/a
    		 3.18%

    Dividend Growth (YoY)

    n/a
    		 0%

    Payout Ratio

    n/a
    		 38.8%

    Earnings Yield

    n/a
    		 3.06%

    FCF Yield

    n/a
    		 5.31%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for VIVO.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on May 14, 2007. It was a forward split with a ratio of 3:2.

    Last Split Date

    n/a
    		 May 14, 2007

    Split Type

    n/a
    		 forward

    Split Ratio

    n/a
    		 3:2

    Scores

    Altman Z-Score

    n/a
    		 9.28

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist